Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Clinical trial NCT07088588 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07088588
Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancer Metastatic Solid Tumor Ovarian Cancer Breast Cancer BRCA Mutation HRR Deficiency

Start date: 2025-07-31
Primary completion: 2028-07-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.